Pharma companies are finding it difficult to hire data science talent—we think it’ll make AI drug discovery startups like Valo (who is going public via a $2.8B SPAC merger) attractive partners.

For context, Komodo Health offers healthcare stakeholders a suite of solutions based on its proprietary AI-powered analytics tool, Healthcare Map, which tracks over 320 million deidentified patient encounters to glean real-world insights. We spoke to Komodo Health’s CEO, Arif Nathoo, to learn more about the massive funding haul and where Komodo is headed—here’s what he told us:.

Pharma companies are utilizing AI to accelerate the time-consuming—and expensive—drug discovery process. Traditionally, it takes pharmaceutical companies an average of 10 years and $3 billion to bring a drug to market.

Magellan AI. Netflix. Nielsen. Reelgood. Sensor Tower. The Wall Street Journal. Tubular Labs. Vulture.

The news: Cleveland Clinic and IBM struck a ten-year partnership to use AI and quantum computing tech to facilitate healthcare research initiatives, like precision medicine and drug discovery. As part of the deal, Cleveland Clinic will get to install IBM’s first private sector quantum computing system.

AI-powered discovery solutions are a must in today’s business environment, allowing marketers to deliver more accurate and relevant results to the buyer, while also increasing business conversions, according to Rightpoint.

It plans to combine its collection of real-world patient data with Kantar’s tech to “power drug discovery” and speed up the time it takes to conduct clinical trials, per an April Cerner press release. Plus, Cerner is in a long-term partnership with the Department of Veterans Affairs (VA) to modernize its EHR system—though it’ll take some time before Cerner can reap the financial benefits.